Amid doubts as to its viability, R360 releases statement via Mike Tindall stating launch delayed by two years to 2028; In ...
November 28, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) (the "Company"), a clinical-stage biopharmaceutical company focused on the development ...